CD4 and leukemia: These CTLs, which include both CD8+ and CD4+ T cells, have high cytotoxic potential, as they are able to recognize and lyse target cells pulsed with NPM1mut peptides and, more importantly, they efficiently kill autologous or, in the case of donor, HLA partially matched NPM1mut-positive leukemia blasts.